News

KENVUE Hedge Fund Activity We have seen 533 institutional investors add shares of KENVUE stock to their portfolio, and 492 decrease their positions in their most recent quarter.
Shares of Kenvue, the maker of Tylenol and Benadryl, could be a remedy for investors left aching by the stock market’s selloff, analysts at Wolfe Research say. The company has struggled since it ...
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and r ...
Shares of Kenvue Inc. KVUE shed 2.08% to $23.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining ...
Shares of Kenvue Inc. KVUE advanced 1.53% to $23.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.63% to 5,604.14 ...
Currently, Kenvue, Inc. has an average volume of 15.8M. Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock.
KVUE market cap is currently $44.15B and has a P/E ratio of 42.92. Based on the recent corporate insider activity of 37 insiders, corporate insider sentiment is negative on the stock.
On this episode of Stock Movers: - Coinbase (COIN) share are gaining after Argus Research Corp initiated coverage of the stock with a recommendation of buy and a $400 price target.
In that case, it may interest you to know that investing $26,000 into Kenvue (KVUE 1.53%), a high-yield consumer staples stock, could earn you at least $1,000 in dividend income per year.
The stock has a high yield at 3.9%, which is significantly higher than well-known Dividend Kings like Coca-Cola or Procter & Gamble. And finally, Kenvue sports a reasonable valuation -- with a ...
On this episode of Stock Movers: - Coinbase (COIN) shares rise. Cryptocurrency-exposed stocks rose after Bitcoin breached $120,000 for the first time, with investor enthusiasm showing few signs of ...